Pharmacometabolomics identifies dodecanamide and leukotriene B4 dimethylamide as a predictor of chemosensitivity for patients with acute myeloid leukemia treated with cytarabine and anthracycline.

Tan, Guangguo; Zhao, Bingbing; Li, Yanqing; Liu, Xi; Zou, Zhilan; Wan, Jun; Yao, Ye; Xiong, Hong; Wang, Yanyu

Tan, Guangguo; Zhao, Bingbing; Li, Yanqing; Liu, Xi; Zou, Zhilan; Wan, Jun; Yao, Ye; Xiong, Hong; Wang, Yanyu.

Afiliação

Tan G; School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.
Zhao B; Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China.
Li Y; Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China.
Liu X; Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China.
Zou Z; Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China.
Wan J; Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China.
Yao Y; Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China.
Xiong H; Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China.
Wang Y; Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China.

Oncotarget ; 8(51): 88697-88707, 2017 Oct 24.

Article em En | MEDLINE | ID: mdl-29179468

Palavras-chave

acute myeloid leukemia; chemosensitivity; liquid chromatography-mass spectrometry; metabolomics; pharmacometabolomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google